Literature DB >> 26653714

Drug-motivated behavior in rats with lesions of the thalamic orosensory area.

Jennifer E Nyland1, Danielle N Alexander1, Patricia S Grigson1.   

Abstract

Rats suppress intake of a palatable taste cue when paired with a rewarding or an aversive stimulus in appetitive or aversive conditioning, respectively. A similar phenomenon occurs with drugs of abuse, but the nature of this conditioning has been subject for debate. While relatively little is known about the underlying neural circuitry, we recently reported bilateral lesions of the thalamic trigeminal orosensory area isolate drug-induced suppression of intake of a taste cue. The lesion blocks avoidance of the taste cue when paired with experimenter delivered drugs of abuse, yet has no effect on avoidance of the same cue when paired with an aversive agent or when it predicts access to a highly palatable sucrose solution. We hypothesize the lesion may blunt the rewarding properties of the drug. To test this, we used a runway apparatus, as running speed has been shown to increase with increasing reward value. Our hypothesis was supported by failure of the lesioned rats to increase running speed for morphine. Interestingly, lesioned rats did avoid intake of the drug-paired cue when presented in the runway apparatus and displayed naloxone-precipitated withdrawal. Using a partial crossover design, the lesion prevented avoidance of a cocaine-paired cue when presented in the home cage. We conclude that the lesion disrupts avoidance of a taste cue in anticipation of the rewarding properties of a drug but, at least in the presence of contextual cues, allows for avoidance of a taste cue as it elicits the onset of an aversive conditioned state of withdrawal. (c) 2016 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26653714      PMCID: PMC6148348          DOI: 10.1037/bne0000114

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  68 in total

1.  Taste reactivity responses elicited by reinforcing drugs: a dose-response analysis.

Authors:  L A Parker
Journal:  Behav Neurosci       Date:  1991-12       Impact factor: 1.912

2.  Conditioned sucrose aversions produced by naloxone-precipitated withdrawal from acutely administered morphine.

Authors:  R V McDonald; L A Parker; S Siegel
Journal:  Pharmacol Biochem Behav       Date:  1997-12       Impact factor: 3.533

3.  Morphine-induced suppression of saccharin intake is correlated with elevated corticosterone levels.

Authors:  F Gomez; N A Leo; P S Grigson
Journal:  Brain Res       Date:  2000-04-28       Impact factor: 3.252

4.  An opponent-process theory of motivation. I. Temporal dynamics of affect.

Authors:  R L Solomon; J D Corbit
Journal:  Psychol Rev       Date:  1974-03       Impact factor: 8.934

5.  Morphine dependent rats as a model for evaluating potential addiction liability of analgesic compounds.

Authors:  O J Lorenzetti; L F Sancilio
Journal:  Arch Int Pharmacodyn Ther       Date:  1970-02

6.  Aversive conditioning by ethanol in the rat.

Authors:  D Lester; M Nachman; J Le Magnen
Journal:  Q J Stud Alcohol       Date:  1970-09

7.  Pontine and thalamic influences on fluid rewards: III. Anticipatory contrast for sucrose and corn oil.

Authors:  Nu-Chu Liang; Ralph Norgren; Patricia S Grigson
Journal:  Physiol Behav       Date:  2011-06-16

8.  Assessment of morphine-type physical dependence liability: a screening method using the rat.

Authors:  M Nozaki
Journal:  Psychopharmacology (Berl)       Date:  1976-06-23       Impact factor: 4.530

9.  Conditioned place preference: an evaluation of morphine's positive reinforcing properties.

Authors:  A Blander; T Hunt; R Blair; Z Amit
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Bilateral lesions in a specific subregion of posterior insular cortex impair conditioned taste aversion expression in rats.

Authors:  Lindsey A Schier; Ginger D Blonde; Alan C Spector
Journal:  J Comp Neurol       Date:  2015-07-29       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.